MVRx Obtains $6,807,519 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    3314 Haskins Dr. Belmont, CA 94002 USA
  • Company Description
    The ARTO System, the company’s initial platform, targets mitral valve regurgitation associated with congestive heart failure. Simple venous based delivery provides exceptional control resulting in an easy, reliable, and predictable repair.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Not an offer or solicitation for sale of securities. 24 investors participated in the offering. Please contact technology company for solicitation details.
  • M&A Terms
  • Venture Investor

Trending on Xconomy